Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory G Burrows

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic miceArthur A Vandenbark, Cathleen Rich, Jeff Mooney, et al.
Translational Vision Science & Technology|September 20, 2013
Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human UveitisMadison Kyger, Aneta Worley, Jianya Huan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switchJianya Huan, Sandhya Subramanian, Richard Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritisJianya Huan, Laurie J Kaler, Jeffery L Mooney, et al.
European Journal of Immunology|April 29, 2004
Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic miceCathleen Rich, Jason M Link, Alex Zamora, et al.
Journal of Neuroscience Research|June 14, 2005
Decreased FOXP3 levels in multiple sclerosis patientsJianya Huan, Nicole Culbertson, Leslie Spencer, et al.
Journal of Neurochemistry|August 11, 2006
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAEChunhe Wang, Bruce G Gold, Laurie J Kaler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
Metabolic Brain Disease|April 8, 2011
Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in miceSuzan Dziennis, Sarah Mader, Kozaburo Akiyoshi, et al.
European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic miceArthur A Vandenbark, Cathleen Rich, Jeff Mooney, et al.
Translational Vision Science & Technology|September 20, 2013
Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human UveitisMadison Kyger, Aneta Worley, Jianya Huan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switchJianya Huan, Sandhya Subramanian, Richard Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritisJianya Huan, Laurie J Kaler, Jeffery L Mooney, et al.
European Journal of Immunology|April 29, 2004
Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic miceCathleen Rich, Jason M Link, Alex Zamora, et al.
Journal of Neuroscience Research|June 14, 2005
Decreased FOXP3 levels in multiple sclerosis patientsJianya Huan, Nicole Culbertson, Leslie Spencer, et al.
Journal of Neurochemistry|August 11, 2006
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAEChunhe Wang, Bruce G Gold, Laurie J Kaler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
Metabolic Brain Disease|April 8, 2011
Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in miceSuzan Dziennis, Sarah Mader, Kozaburo Akiyoshi, et al.
European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.
Pageof 5